Q3 EPS Estimates for DENTSPLY SIRONA Decreased by Analyst

Key Points

• Analysts at Leerink Partners have revised DENTSPLY SIRONA's Q3 2025 earnings per share estimate from $0.46 to $0.45, with a full-year consensus estimate of $1.84 per share.
• DENTSPLY SIRONA reported Q3 earnings of $0.52 per share, exceeding analyst expectations of $0.50, but revenue declined by 4.9% year-over-year.
• Investors will receive a quarterly dividend of $0.16 per share on October 10th, representing a yield of 4.9%.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) - Analysts at Leerink Partnrs decreased their Q3 2025 earnings per share (EPS) estimates for DENTSPLY SIRONA in a research report issued on Thursday, August 7th. Leerink Partnrs analyst M. Cherny now anticipates that the medical instruments supplier will post earnings per share of $0.45 for the quarter, down from their prior estimate of $0.46. The consensus estimate for DENTSPLY SIRONA's current full-year earnings is $1.84 per share. Leerink Partnrs also issued estimates for DENTSPLY SIRONA's Q4 2025 earnings at $0.48 EPS, FY2027 earnings at $2.34 EPS and FY2028 earnings at $2.64 EPS.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating analysts' consensus estimates of $0.50 by $0.02. The company had revenue of $936.00 million during the quarter, compared to the consensus estimate of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The firm's quarterly revenue was down 4.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.49 earnings per share.

XRAY has been the topic of a number of other research reports. Wall Street Zen lowered DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Barrington Research set a $18.00 price target on DENTSPLY SIRONA and gave the company an "outperform" rating in a research report on Friday, August 8th. Wells Fargo & Company dropped their price objective on DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating on the stock in a research note on Friday, August 8th. Stifel Nicolaus dropped their price objective on DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating on the stock in a research note on Friday, August 8th. Finally, Piper Sandler dropped their price target on DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 30th. Twelve investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, DENTSPLY SIRONA has an average rating of "Hold" and an average price target of $18.64.

DENTSPLY SIRONA Price Performance

NASDAQ XRAY traded down $0.16 during midday trading on Monday, hitting $13.70. The company had a trading volume of 1,401,457 shares, compared to its average volume of 2,999,124. DENTSPLY SIRONA has a twelve month low of $12.16 and a twelve month high of $27.48. The firm has a 50-day moving average price of $15.54 and a 200-day moving average price of $15.79. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13. The company has a market capitalization of $2.73 billion, a PE ratio of -2.89, a P/E/G ratio of 0.81 and a beta of 0.94.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be issued a dividend of $0.16 per share. The ex-dividend date is Friday, September 26th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.7%. DENTSPLY SIRONA's dividend payout ratio is -13.50%.

Institutional Trading of DENTSPLY SIRONA

Several institutional investors have recently added to or reduced their stakes in the business. Envestnet Asset Management Inc. lifted its position in DENTSPLY SIRONA by 9.0% during the first quarter. Envestnet Asset Management Inc. now owns 494,737 shares of the medical instruments supplier's stock valued at $7,391,000 after purchasing an additional 40,936 shares in the last quarter. Brown Advisory Inc. bought a new stake in shares of DENTSPLY SIRONA in the first quarter worth about $679,000. Comerica Bank increased its stake in DENTSPLY SIRONA by 41.2% during the fourth quarter. Comerica Bank now owns 225,080 shares of the medical instruments supplier's stock worth $4,272,000 after acquiring an additional 65,709 shares during the last quarter. Cerity Partners LLC increased its stake in DENTSPLY SIRONA by 268.5% during the fourth quarter. Cerity Partners LLC now owns 65,588 shares of the medical instruments supplier's stock worth $1,294,000 after acquiring an additional 47,788 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC grew its stake in shares of DENTSPLY SIRONA by 39.0% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 53,903 shares of the medical instruments supplier's stock valued at $805,000 after buying an additional 15,117 shares during the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.